PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-18.52%
Negative net income growth while ORCL stands at 42.14%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
38.80%
D&A growth well above ORCL's 1.97%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-94.21%
Negative yoy deferred tax while ORCL stands at 159.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
2.66%
Less SBC growth vs. ORCL's 10.45%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
11.69%
Slight usage while ORCL is negative at -50.68%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-314.43%
Both yoy AR lines negative, with ORCL at -11758.82%. Martin Whitman would suspect an overall sector lean approach or softer demand.
38.58%
Inventory shrinking or stable vs. ORCL's 428.57%, indicating lean supply management. David Dodd would confirm no demand shortfall.
220.53%
Lower AP growth vs. ORCL's 494.92%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
66.68%
Lower 'other working capital' growth vs. ORCL's 291.32%. David Dodd would see fewer unexpected short-term demands on cash.
-13.50%
Negative yoy while ORCL is 422.47%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-5.79%
Negative yoy CFO while ORCL is 47.21%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-11.58%
Both yoy lines negative, with ORCL at -4.76%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-3483.44%
Negative yoy acquisition while ORCL stands at 67.98%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-10.08%
Negative yoy purchasing while ORCL stands at 3.23%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
18.61%
We have some liquidation growth while ORCL is negative at -37.36%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-613.04%
Both yoy lines negative, with ORCL at -147.67%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-107.98%
Both yoy lines negative, with ORCL at -330.23%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-566.67%
We cut debt repayment yoy while ORCL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
3.55%
We slightly raise equity while ORCL is negative at -18.30%. John Neff sees competitor possibly preserving share count or buying back shares.
36.59%
Repurchase growth above 1.5x ORCL's 3.33%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.